AB
Amalgamated Bank Portfolio holdings
AUM
$13B
1-Year Return
23.92%
This Quarter Return
-3%
1 Year Return
+23.92%
3 Year Return
+105.94%
5 Year Return
+196.1%
10 Year Return
+496.3%
AUM
$12.9B
AUM Growth
-$678M
(-5%)
Cap. Flow
+$9.75M
Cap. Flow
% of AUM
0.08%
Top 10 Holdings %
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24
Top Buys
| 1 |
Accenture
ACN
|
+$60.7M |
| 2 |
Medtronic
MDT
|
+$37.6M |
| 3 |
Apple
AAPL
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.2M |
| 5 |
Linde
LIN
|
+$25.1M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$21.3M |
| 2 |
iShares Russell 3000 ETF
IWV
|
+$15.3M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$13.9M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$13.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10.9M |
Sector Composition
| 1 | Technology | 24.66% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 13.15% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANAT
2001
DELISTED
American National Group, Inc. Common Stock
ANAT
| $170K | ﹤0.01% |
+900
| New | +$170K |
|
2002
Empire State Realty Trust
ESRT
$1.34B
| $169K | ﹤0.01% |
17,257
-1,284
| -7% | -$12.6K |
|
2003
BGC Group
BGC
$4.82B
| $168K | ﹤0.01% |
38,169
-3,666
| -9% | -$16.1K |
|
2004
Delek US
DK
$1.7B
| $168K | ﹤0.01% |
+7,923
| New | +$168K |
|
2005
PAR Technology
PAR
$1.81B
| $167K | ﹤0.01% |
4,129
-276
| -6% | -$11.2K |
|
|
RDUS
2006
DELISTED
Radius Recycling
RDUS
| $167K | ﹤0.01% |
+3,219
| New | +$167K |
|
2007
TriMas Corp
TRS
$1.59B
| $167K | ﹤0.01% |
5,216
-413
| -7% | -$13.2K |
|
2008
Universal Insurance Holdings
UVE
$724M
| $167K | ﹤0.01% |
12,390
-734
| -6% | -$9.89K |
|
|
SUMO
2009
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $167K | ﹤0.01% |
14,298
-1,030
| -7% | -$12K |
|
|
CCXI
2010
DELISTED
ChemoCentryx, Inc.
CCXI
| $167K | ﹤0.01% |
6,669
-529
| -7% | -$13.2K |
|
2011
Atlanta Braves Holdings Series B
BATRK
$2.63B
| $166K | ﹤0.01% |
+5,949
| New | +$166K |
|
|
LAND
2012
Gladstone Land Corp
LAND
$320M
| $166K | ﹤0.01% |
+4,558
| New | +$166K |
|
2013
Opko Health
OPK
$1.12B
| $166K | ﹤0.01% |
48,211
-3,586
| -7% | -$12.3K |
|
2014
FibroGen
FGEN
$49.3M
| $165K | ﹤0.01% |
549
-45
| -8% | -$13.5K |
|
2015
Bally's
BALY
$487M
| $164K | ﹤0.01% |
5,325
-422
| -7% | -$13K |
|
2016
Cytek Biosciences
CTKB
$518M
| $164K | ﹤0.01% |
+15,225
| New | +$164K |
|
2017
Sinclair Inc
SBGI
$970M
| $164K | ﹤0.01% |
+5,842
| New | +$164K |
|
2018
Stock Yards Bancorp
SYBT
$2.27B
| $164K | ﹤0.01% |
3,092
-227
| -7% | -$12K |
|
|
UMH
2019
UMH Properties
UMH
$1.29B
| $164K | ﹤0.01% |
+6,653
| New | +$164K |
|
|
LYLT
2020
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $164K | ﹤0.01% |
9,941
-461
| -4% | -$7.61K |
|
|
LADR
2021
Ladder Capital
LADR
$1.49B
| $163K | ﹤0.01% |
13,713
-1,086
| -7% | -$12.9K |
|
|
ATRI
2022
DELISTED
Atrion Corp
ATRI
| $163K | ﹤0.01% |
+228
| New | +$163K |
|
2023
Krystal Biotech
KRYS
$4.14B
| $162K | ﹤0.01% |
+2,437
| New | +$162K |
|
2024
Anika Therapeutics
ANIK
$123M
| $161K | ﹤0.01% |
6,428
-386
| -6% | -$9.67K |
|
2025
BridgeBio Pharma
BBIO
$9.8B
| $160K | ﹤0.01% |
15,794
-1,398
| -8% | -$14.2K |
|